The current institutional shareholding score of Evotec SE is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 2.69%, representing a quarter-over-quarter decrease of 9.27%. The largest institutional shareholder is Diamond Hill Capital, holding a total of 376.31K shares, representing 0.12% of shares outstanding, with 9.09% increase in holdings.